Y-Intercept (HK)’s CAMP4 Therapeutics CAMP Stock Holding History

Y-Intercept (HK)’s Portfolio CAMP Stock Details CAMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-30,942	Closed	-$135K	–	1624
2026 Q2	$135K	Buy	+30,942	New	+$133K	﹤0.01%	1595

Other funds holding CAMP

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Y-Intercept (HK)'s CAMP Position: Q3 2026 in Review

Y-Intercept (HK) sold out of CAMP4 Therapeutics (CAMP) in Q3 2026, closing a stake of 30,942 shares — an estimated $135K sold.

Y-Intercept (HK) first reported a position in CAMP in Q2 2026 and held it in 1 quarter. The position peaked at $135K in Q2 2026. 4 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.

Y-Intercept (HK) reported no remaining CAMP4 Therapeutics position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 30,942 CAMP4 Therapeutics shares in Q3 2026, an estimated $135K.
Y-Intercept (HK) first reported a position in CAMP4 Therapeutics in Q2 2026 and held it in 1 quarter.
Y-Intercept (HK)'s CAMP4 Therapeutics position peaked at $135K in Q2 2026.
4 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.